Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/888
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurphy, Declan-
dc.contributor.authorCostello, Anthony-
dc.contributor.authorHall, Rohan-
dc.contributor.authorTong, Raymond-
dc.contributor.authorGoel, Rajiv-
dc.date.accessioned2016-11-16T03:39:42Z-
dc.date.available2016-11-16T03:39:42Z-
dc.date.issued2008-12-
dc.identifier.citationANZ J Surg. 2008 Dec;78(12):1076-81.en_US
dc.identifier.issn1445-2197en_US
dc.identifier.urihttp://hdl.handle.net/11434/888-
dc.description.abstractThere is increasing patient and surgeon interest in robotic-assisted surgery, particularly with the proliferation of da Vinci surgical systems throughout the world. There is much debate over the usefulness and cost-effectiveness of these systems. The currently available robotic surgical technology is described. Published data relating to the da Vinci system are reviewed and the current status of surgical robotics within Australia and New Zealand is assessed. The first da Vinci system in Australia and New Zealand was installed in 2003. Four systems had been installed by 2006 and seven systems are currently in use. Most of these are based in private hospitals. Technical advantages of this system include 3-D vision, enhanced dexterity and improved ergonomics when compared with standard laparoscopic surgery. Most procedures currently carried out are urological, with cardiac, gynaecological and general surgeons also using this system. The number of patients undergoing robotic-assisted surgery in Australia and New Zealand has increased fivefold in the past 4 years. The most common procedure carried out is robotic-assisted laparoscopic radical prostatectomy. Published data suggest that robotic-assisted surgery is feasible and safe although the installation and recurring costs remain high. There is increasing acceptance of robotic-assisted surgery, especially for urological procedures. The da Vinci surgical system is becoming more widely available in Australia and New Zealand. Other surgical specialties will probably use this technology. Significant costs are associated with robotic technology and it is not yet widely available to public patients.en_US
dc.publisherWileyen_US
dc.subjectGeneral Surgeryen_US
dc.subjectInstrumentationen_US
dc.subjectLaparoscopyen_US
dc.subjectRoboticsen_US
dc.subjectTrendsen_US
dc.subjectSurgical Procedures, Operativeen_US
dc.subjectda Vinci Surgical Systemen_US
dc.subjectRobotic-Assisted Laparoscopic Radical Prostatectomyen_US
dc.subjectRobotic-Assisted Surgeryen_US
dc.subjectUroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleRobotic technology in surgery: current status in 2008.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1111/j.1445-2197.2008.04754.xen_US
dc.identifier.journaltitleANZ Journal of Surgeryen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/19087046en_US
dc.description.affiliatesDepartment of Urology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.en_US
dc.type.studyortrialReviewen_US
dc.type.contenttypeTexten_US
Appears in Collections:Epworth Prostate Centre
Health Administration
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.